ONE Life Sciences Network | ONE

The network meetings deliver high-quality insights into sector business-critical topics. Speakers, drawn from across the UK, are leaders in their fields and have included senior representatives from Innovate UK, BioCity Group, Scottish Life Sciences Industry Leadership Group, the NHS and academia.

With more than 160 life sciences professionals attending the events, there is a fantastic opportunity to meet with your peers, share experiences, learn from each other and become part of this growing industry network. The ONE Life Sciences Network meetings are amongst the highest attended in the sector in Scotland.

The knowledge shared by sector professionals broadens horizons, inspires new ways of thinking and provides access to practical support to all in the network.

High profile speakers have included Ian Campbell, interim executive chair of Innovate UK, Dave Tudor, co-chair of the Scottish Life Sciences Industry Leadership Group, Jamie Coleman, co-founder of CodeBase and UltraHuman, and Professor Siladitya Bhattacharya, head of the School of Medicine, Medical Sciences and Nutrition at the University of Aberdeen.

Scottish Life Sciences Summit

In February 2020, ONE partnered with The Times and Sunday Times Scotland to deliver the inaugural Scottish Life Sciences Summit in Aberdeen. Keynote speakers included Nobel laureate Sir Greg Winter and Dr John McCafferty. The pair were co-founders of Cambridge Antibody Technology in 1989, that became the UK’s biggest biotech success story and sold for more than £700 million in 2006. They discovered Humira, the world’s biggest-selling drug with annual sales of circa $20 billion.

More than 140 life scientists from industry, academia and clinical backgrounds attended the one-day summit. Speakers and panel discussions covered the region’s collaborative environment, strengths in biologics, showcased innovative Aberdeen-based life sciences companies, explored finance and investment for the sector, and heard clinical perspectives on the application of biotherapeutics.

The event highlighted the regional ambition to double the number of life sciences companies in and around Aberdeen and develop drugs and products to tackle modern health challenges, including cancer, diabetes and antimicrobial resistance. North east companies taking part included Elasmogen, EnteroBiotix, NovaBiotics and TauRX.

The summit was supported by the University of Aberdeen and global investment managers Baillie Gifford.